The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Anacor Pharmaceuticals Inc | COM | 032420101 | 38,006 | 1,178,474 | SH | SOLE | 1,178,474 | 0 | 0 | ||
| Avalanche Biotechnologies Inc | COM | 05337G107 | 57,956 | 1,102,735 | SH | SOLE | 1,102,735 | 0 | 0 | ||
| Avalanche Biotechnologies Inc | COM | 05337G107 | 15,120 | 280,000 | SH | DFND | 280,000 | 0 | 0 | ||
| BioCryst Pharmaceuticals Inc | COM | 09058V103 | 21,211 | 1,744,356 | SH | SOLE | 1,744,356 | 0 | 0 | ||
| Coherus Biosciences Inc | COM | 19249H103 | 8,839 | 611,010 | SH | SOLE | 611,010 | 0 | 0 | ||
| Coherus Biosciences Inc | COM | 19249H103 | 4,231 | 259,259 | SH | DFND | 259,259 | 0 | 0 | ||
| Cynapsus Therapeutics Inc | COM | 23257Y701 | 439 | 461,025 | SH | SOLE | 461,025 | 0 | 0 | ||
| Cynapsus Therapeutics Inc | COM | 23257Y701 | 1,024 | 1,075,725 | SH | DFND | 1,075,725 | 0 | 0 | ||
| DBV Technologies | COM | F2927N109 | 23,995 | 463,643 | SH | SOLE | 463,643 | 0 | 0 | ||
| DBV Technologies | COM | F2927N109 | 10,460 | 230,167 | SH | DFND | 230,167 | 0 | 0 | ||
| Dyax Corp | COM | 26746E103 | 14,069 | 1,000,659 | SH | SOLE | 1,000,659 | 0 | 0 | ||
| Flamel Technologies S.A. | COM | 338488109 | 8,565 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| GW Pharmaceuticals | COM | 36197T103 | 21,106 | 311,853 | SH | SOLE | 311,853 | 0 | 0 | ||
| Heron Therapeutics Inc | COM | 427746102 | 11,023 | 1,095,734 | SH | SOLE | 1,095,734 | 0 | 0 | ||
| Juno Therapeutics Inc | COM | 48205A109 | 74,326 | 1,749,999 | SH | SOLE | 1,749,999 | 0 | 0 | ||
| Lipocine Inc | COM | 53630X104 | 3,524 | 669,921 | SH | SOLE | 669,921 | 0 | 0 | ||
| Ocera Therapeutics | COM | 67552A108 | 4,483 | 703,730 | SH | SOLE | 703,730 | 0 | 0 | ||
| OHR Pharmaceutical | COM | 67778H200 | 3,978 | 477,000 | SH | SOLE | 477,000 | 0 | 0 | ||
| Radius Health Inc | COM | 750469108 | 9,077 | 233,294 | SH | SOLE | 233,294 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 1,824 | 106,920 | SH | SOLE | 106,920 | 0 | 0 | ||
| Stemline Therapeutics Inc | COM | 85858C107 | 4,256 | 249,480 | SH | DFND | 249,480 | 0 | 0 | ||
| Sunesis Pharmaceuticals | COM | 867328502 | 410 | 160,857 | SH | SOLE | 160,857 | 0 | 0 | ||
| Sunesis Pharmaceuticals | COM | 867328502 | 957 | 375,332 | SH | DFND | 375,332 | 0 | 0 | ||
| TherapeuticsMD Inc | COM | 88338N107 | 3,767 | 846,500 | SH | SOLE | 846,500 | 0 | 0 | ||
| Zafgen Inc | COM | 98885E103 | 16,699 | 541,480 | SH | SOLE | 541,480 | 0 | 0 | ||
| ZS Pharma Inc | COM | 98979G105 | 4,157 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||